Fatty Acid Conjugates of Toluidine Blue O as Amphiphilic Photosensitizers: Synthesis, Solubility, Photophysics and Photochemical Properties†
- 3 July 2020
- journal article
- research article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 97 (1) , 71-79
Abstract
Toluidine blue O (TBO) is a water‐soluble photosensitizer that has been used in photodynamic antimicrobial and anticancer treatments, but suffers from limited solubility in hydrophobic media. In an effort to incrementally increase TBO’s hydrophobicity, we describe the synthesis of hexanoic (TBOC6) and myristic (TBOC14) fatty acid derivatives of TBO formed in low to moderate percent yields by condensation with the free amine site. Covalently linking 6 and 14 carbon chains led to modifications of not only TBO’s solubility, but also its photophysical and photochemical properties. TBOC6 and TBOC14 derivatives were more soluble in organic solvents and showed hypsochromic shifts in their absorption and emission bands. The solubility in phosphate buffer solution was low for both TBOC6 and TBOC14, but unexpectedly slightly greater in the latter. Both TBOC6 and TBOC14 showed decreased triplet excited‐state lifetimes and singlet oxygen quantum yields in acetonitrile, which was attributed to heightened aggregation of these conjugates particularly at high concentrations due to the hydrophobic “tails.” While in diluted aqueous buffer solution, indirect measurements showed similar efficiency in singlet oxygen generation for TBOC14 compared to TBO. This work demonstrates a facile synthesis of fatty acid TBO derivatives leading to amphiphilic compounds with a delocalized cationic “head” group and hydrophobic “tails” for potential to accumulate into biological membranes or membrane/aqueous interfaces in PDT applications.Keywords
Funding Information
- National Science Foundation (CHE‐1856765)
- Fondo Nacional de Desarrollo Científico y Tecnológico (1160443)
This publication has 66 references indexed in Scilit:
- The good, the bad, and the ugly–controlling singlet oxygen through design of photosensitizers and delivery systems for photodynamic therapyPhotochemical & Photobiological Sciences, 2018
- Type I and Type II Photosensitized Oxidation Reactions: Guidelines and Mechanistic PathwaysPhotochemistry and Photobiology, 2017
- Photodynamic Efficiency: From Molecular Photochemistry to Cell DeathInternational Journal of Molecular Sciences, 2015
- DNA damage by singlet oxygen and cellular protective mechanismsMutation Research - Reviews in Mutation Research, 2012
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Oncologic photodynamic therapy photosensitizers: A clinical reviewPhotodiagnosis and Photodynamic Therapy, 2010
- Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic TherapyPhotochemistry and Photobiology, 2009
- Milestones in the development of photodynamic therapy and fluorescence diagnosisPhotochemical & Photobiological Sciences, 2007
- The oxidative environment and protein damageBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2005
- Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localizationPhotodiagnosis and Photodynamic Therapy, 2004